Persistence of new-onset diabetes in the post-acute phase of COVID-19

• Type of Material: Article
• Authors: Sathish Thirunavukkarasu, Emory University; Mary Chandrika Anton, Sree Balaji Medical College & Hospital
• Language: English
• Date: 2022-07-21
• Publisher: SPRINGER INDIA
• Publication Version: Final Published Version
• Copyright Statement: © The Author(s), under exclusive licence to Research Society for Study of Diabetes in India 2022
• Final Published Version (URL): http://dx.doi.org/10.1007/s13410-022-01119-7
• Title of Journal or Parent Work: INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES
• Start Page: 1
• End Page: 2
• Keywords: Science & Technology; new-onset diabetes; Life Sciences & Biomedicine; Endocrinology & Metabolism; COVID-19; long-covid; diabetes
• Research Categories: Biology, Virology; Health Sciences, Public Health

Abstract

The article by Madhu [1] discusses the challenges in providing post-COVID-19 diabetes care. In addition to these challenges, we like to point out that the persistence of new-onset diabetes (NOD) after recovery from COVID-19 is a crucial challenge. A meta-analysis of 8 studies with 3711 COVID-19 patients (492 NOD cases) showed that 14% of hospitalized COVID-19 patients had NOD during the acute phase of the illness [2]. Since studies included in this meta-analysis were conducted in mid-2020, it was not known whether NOD is transient or if it would persist after recovery. Given the pandemic is ongoing for more than 2 years, reports on the long-term effects of COVID-19 are emerging.